2-(3-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

tert-Butyl (2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate, 98.0%, 25g

tert-Butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 250mg

(4-Bromo-3-chlorophenyl)methanamine hydrochloride, 97.0%, 25g

(S)-4-(1-Hydroxyethyl)pyridine>97.0%(GC)(T)5g

Glycylglycine, 10 g

Ethyl 5-Amino-1-methylpyrazole-4-carboxylate>98.0%(GC)(T)25g

4-(allyloxy)-2-chloro-5-ethoxybenzaldehyde, 95.0%, 5g

5-(aminomethyl)-2-pyrrolidinone oxalate, 95.0%, 1g

iScope IS.1158-EPLi Biocular with E-plan IOS objectives and Rackless cross table (infinity - ergonomic tilting head)

1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)pyrrolidine, 98%, 5g

N-Methoxy-N,1-dimethylpiperidine-4-carboxamide, 95.0%, 1g

1,4-Diphenoxybenzene>98.0%(GC)25g